▶ 調査レポート

メタボリックシンドロームの世界市場:市場規模・現状・予測

• 英文タイトル:Global Metabolic Syndrome Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。メタボリックシンドロームの世界市場:市場規模・現状・予測 / Global Metabolic Syndrome Market Size, Status and Forecast 2019-2025 / QYR9ST03449資料のイメージです。• レポートコード:QYR9ST03449
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、メタボリックシンドロームの世界市場について調査・分析し、メタボリックシンドロームの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(糖尿病、肥満、高コレステロール血症、リソソーム蓄積症)、用途別(病院、診療所、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のメタボリックシンドローム市場動向
・主要企業別マーケットシェア
・メタボリックシンドロームの種類別市場規模2014-2019
(糖尿病、肥満、高コレステロール血症、リソソーム蓄積症)
・メタボリックシンドロームの用途別市場規模2014-2019
(病院、診療所、その他)
・メタボリックシンドロームの北米市場:主要企業・種類別/用途別市場規模
・メタボリックシンドロームのヨーロッパ市場:主要企業・種類別/用途別市場規模
・メタボリックシンドロームの中国市場:主要企業・種類別/用途別市場規模
・メタボリックシンドロームの日本国内市場:主要企業・種類別/用途別市場規模
・メタボリックシンドロームの東南アジア市場:主要企業・種類別/用途別市場規模
・メタボリックシンドロームのインド市場:主要企業・種類別/用途別市場規模
・メタボリックシンドロームの中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Novo Nordisk、Sanofi、Merck、AstraZeneca、Eli Lily、AbbVie、Actelion Pharmaceuticals、Adocia、Aegerion Pharmaceuticals、Akros Pharma、Alnylam Pharmaceuticals、Amarin、nAmgen、Amicus Therapeutics、Arbutus Biopharma)
・メタボリックシンドロームの市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.
In 2018, the global Metabolic Syndrome market size was 24600 million US$ and it is expected to reach 36700 million US$ by the end of 2025, with a CAGR of 5.1% during 2019-2025.

This report focuses on the global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Syndrome development in United States, Europe and China.

The key players covered in this study
Novo Nordisk
Sanofi
Merck
AstraZeneca
Eli Lily
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
nAmgen
Amicus Therapeutics
Arbutus Biopharma

Market segment by Type, the product can be split into
Diabetes
Obesity
Hypercholesterolemia
Lysosomal storage diseases

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Metabolic Syndrome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metabolic Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metabolic Syndrome Market Size Growth Rate by Type (2014-2025)
1.4.2 Diabetes
1.4.3 Obesity
1.4.4 Hypercholesterolemia
1.4.5 Lysosomal storage diseases
1.5 Market by Application
1.5.1 Global Metabolic Syndrome Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metabolic Syndrome Market Size
2.2 Metabolic Syndrome Growth Trends by Regions
2.2.1 Metabolic Syndrome Market Size by Regions (2014-2025)
2.2.2 Metabolic Syndrome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metabolic Syndrome Market Size by Manufacturers
3.1.1 Global Metabolic Syndrome Revenue by Manufacturers (2014-2019)
3.1.2 Global Metabolic Syndrome Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metabolic Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Metabolic Syndrome Key Players Head office and Area Served
3.3 Key Players Metabolic Syndrome Product/Solution/Service
3.4 Date of Enter into Metabolic Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metabolic Syndrome Market Size by Type (2014-2019)
4.2 Global Metabolic Syndrome Market Size by Application (2014-2019)

5 United States
5.1 United States Metabolic Syndrome Market Size (2014-2019)
5.2 Metabolic Syndrome Key Players in United States
5.3 United States Metabolic Syndrome Market Size by Type
5.4 United States Metabolic Syndrome Market Size by Application

6 Europe
6.1 Europe Metabolic Syndrome Market Size (2014-2019)
6.2 Metabolic Syndrome Key Players in Europe
6.3 Europe Metabolic Syndrome Market Size by Type
6.4 Europe Metabolic Syndrome Market Size by Application

7 China
7.1 China Metabolic Syndrome Market Size (2014-2019)
7.2 Metabolic Syndrome Key Players in China
7.3 China Metabolic Syndrome Market Size by Type
7.4 China Metabolic Syndrome Market Size by Application

8 Japan
8.1 Japan Metabolic Syndrome Market Size (2014-2019)
8.2 Metabolic Syndrome Key Players in Japan
8.3 Japan Metabolic Syndrome Market Size by Type
8.4 Japan Metabolic Syndrome Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metabolic Syndrome Market Size (2014-2019)
9.2 Metabolic Syndrome Key Players in Southeast Asia
9.3 Southeast Asia Metabolic Syndrome Market Size by Type
9.4 Southeast Asia Metabolic Syndrome Market Size by Application

10 India
10.1 India Metabolic Syndrome Market Size (2014-2019)
10.2 Metabolic Syndrome Key Players in India
10.3 India Metabolic Syndrome Market Size by Type
10.4 India Metabolic Syndrome Market Size by Application

11 Central & South America
11.1 Central & South America Metabolic Syndrome Market Size (2014-2019)
11.2 Metabolic Syndrome Key Players in Central & South America
11.3 Central & South America Metabolic Syndrome Market Size by Type
11.4 Central & South America Metabolic Syndrome Market Size by Application

12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metabolic Syndrome Introduction
12.1.4 Novo Nordisk Revenue in Metabolic Syndrome Business (2014-2019)
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metabolic Syndrome Introduction
12.2.4 Sanofi Revenue in Metabolic Syndrome Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metabolic Syndrome Introduction
12.3.4 Merck Revenue in Metabolic Syndrome Business (2014-2019)
12.3.5 Merck Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metabolic Syndrome Introduction
12.4.4 AstraZeneca Revenue in Metabolic Syndrome Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Eli Lily
12.5.1 Eli Lily Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metabolic Syndrome Introduction
12.5.4 Eli Lily Revenue in Metabolic Syndrome Business (2014-2019)
12.5.5 Eli Lily Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metabolic Syndrome Introduction
12.6.4 AbbVie Revenue in Metabolic Syndrome Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Actelion Pharmaceuticals
12.7.1 Actelion Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metabolic Syndrome Introduction
12.7.4 Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2014-2019)
12.7.5 Actelion Pharmaceuticals Recent Development
12.8 Adocia
12.8.1 Adocia Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metabolic Syndrome Introduction
12.8.4 Adocia Revenue in Metabolic Syndrome Business (2014-2019)
12.8.5 Adocia Recent Development
12.9 Aegerion Pharmaceuticals
12.9.1 Aegerion Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metabolic Syndrome Introduction
12.9.4 Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2014-2019)
12.9.5 Aegerion Pharmaceuticals Recent Development
12.10 Akros Pharma
12.10.1 Akros Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metabolic Syndrome Introduction
12.10.4 Akros Pharma Revenue in Metabolic Syndrome Business (2014-2019)
12.10.5 Akros Pharma Recent Development
12.11 Alnylam Pharmaceuticals
12.12 Amarin
12.13 nAmgen
12.14 Amicus Therapeutics
12.15 Arbutus Biopharma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Metabolic Syndrome Key Market Segments
Table Key Players Metabolic Syndrome Covered
Table Global Metabolic Syndrome Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metabolic Syndrome Market Size Market Share by Type 2014-2025
Figure Diabetes Figures
Table Key Players of Diabetes
Figure Obesity Figures
Table Key Players of Obesity
Figure Hypercholesterolemia Figures
Table Key Players of Hypercholesterolemia
Figure Lysosomal storage diseases Figures
Table Key Players of Lysosomal storage diseases
Table Global Metabolic Syndrome Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Metabolic Syndrome Report Years Considered
Table Global Metabolic Syndrome Market Size 2014-2025 (Million US$)
Figure Global Metabolic Syndrome Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metabolic Syndrome Market Size by Regions 2014-2025 (Million US$)
Table Global Metabolic Syndrome Market Size by Regions 2014-2019 (Million US$)
Table Global Metabolic Syndrome Market Share by Regions 2014-2019
Figure Global Metabolic Syndrome Market Share by Regions 2014-2019
Figure Global Metabolic Syndrome Market Share by Regions 2019
Table Market Top Trends
Table Global Metabolic Syndrome Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metabolic Syndrome Market Share by Manufacturers (2014-2019)
Figure Global Metabolic Syndrome Market Share by Manufacturers in 2018
Table Global Metabolic Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metabolic Syndrome Product/Solution/Service
Table Date of Enter into Metabolic Syndrome Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table Global Metabolic Syndrome Market Size Share by Type (2014-2019)
Figure Global Metabolic Syndrome Market Size Market Share by Type (2014-2019)
Table Global Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table Global Metabolic Syndrome Market Size Share by Application (2014-2019)
Figure Global Metabolic Syndrome Market Size Market Share by Application (2014-2019)
Figure Global Metabolic Syndrome Revenue Market Share by Application in 2018
Figure United States Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table United States Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table United States Key Players Metabolic Syndrome Market Share (2018-2019)
Table United States Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table United States Metabolic Syndrome Market Share by Type (2014-2019)
Table United States Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table United States Metabolic Syndrome Market Share by Application (2014-2019)
Figure Europe Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table Europe Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table Europe Key Players Metabolic Syndrome Market Share (2018-2019)
Table Europe Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table Europe Metabolic Syndrome Market Share by Type (2014-2019)
Table Europe Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table Europe Metabolic Syndrome Market Share by Application (2014-2019)
Figure China Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table China Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table China Key Players Metabolic Syndrome Market Share (2018-2019)
Table China Metabolic Syndrome Market Size by Type (2014-20189) (Million US$)
Table China Metabolic Syndrome Market Share by Type (2014-2019)
Table China Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table China Metabolic Syndrome Market Share by Application (2014-2019)
Figure Japan Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table Japan Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table Japan Key Players Metabolic Syndrome Market Share (2018-2019)
Table Japan Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table Japan Metabolic Syndrome Market Share by Type (2014-2019)
Table Japan Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table Japan Metabolic Syndrome Market Share by Application (2014-2019)
Figure Southeast Asia Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metabolic Syndrome Market Share (2018-2019)
Table Southeast Asia Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metabolic Syndrome Market Share by Type (2014-2019)
Table Southeast Asia Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metabolic Syndrome Market Share by Application (2014-2019)
Figure India Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table India Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table India Key Players Metabolic Syndrome Market Share (2018-2019)
Table India Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table India Metabolic Syndrome Market Share by Type (2014-2019)
Table India Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table India Metabolic Syndrome Market Share by Application (2014-2019)
Figure Central & South America Metabolic Syndrome Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metabolic Syndrome Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metabolic Syndrome Market Share (2018-2019)
Table Central & South America Metabolic Syndrome Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metabolic Syndrome Market Share by Type (2014-2019)
Table Central & South America Metabolic Syndrome Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metabolic Syndrome Market Share by Application (2014-2019)
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Metabolic Syndrome Business (2014-2019) (Million US$)
Figure Novo Nordisk Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lily Company Details
Table Eli Lily Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Eli Lily Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Eli Lily Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table AbbVie Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Actelion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Actelion Pharmaceuticals Recent Development
Table Adocia Company Details
Table Adocia Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Adocia Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Adocia Recent Development
Table Aegerion Pharmaceuticals Company Details
Table Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Aegerion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Aegerion Pharmaceuticals Recent Development
Table Akros Pharma Company Details
Table Akros Pharma Revenue in Metabolic Syndrome Business (2014-2019)(Million US$)
Figure Akros Pharma Revenue Growth Rate in Metabolic Syndrome Business (2014-2019)
Table Akros Pharma Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Amarin Company Details
Table nAmgen Company Details
Table Amicus Therapeutics Company Details
Table Arbutus Biopharma Company Details
Table Global Metabolic Syndrome Market Size by Regions (Million US$) 2019-2025
Figure Global Metabolic Syndrome Market Size Share by Regions (2019-2025)
Figure Global Metabolic Syndrome Market Size Share by Regions in 2025
Figure United States Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure China Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure India Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metabolic Syndrome Market Size Forecast (2019-2025)(Million USD)
Table Global Metabolic Syndrome Market Size by Product (2019-2025) (Million US$)
Figure Global Metabolic Syndrome Market Size by Product (2019-2025)
Figure Global Metabolic Syndrome Market Size by Product in 2025
Table Global Metabolic Syndrome Market Size by Application (2019-2025) (Million US$)
Figure Global Metabolic Syndrome Market Size by Application (2019-2025)
Figure Global Metabolic Syndrome Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources